Rewind Therapeutics

Developer of remyelinating therapies for myelin-related diseases

placeLeuven, Flemish Region, Belgium calendar_todayFounded 2017 groups6 employees language rwdtx.com

Registered entities

Investor mix

8 investors on record; lead investors include Sunstone, Boehringer Ingelheim Venture Fund, M Ventures, PMV.

Investor typeCountShare
Venture capital450%
Bank & private debt113%
Other / undisclosed338%
Coming soon